Curing Versus Managing CLL

December 8, 2014
Adrian Wiestner, MD, PhD

Adrian Wiestner, MD, PhD, senior investigator, National Institutes of Health, discusses curing or managing patients with chronic lymphocytic leukemia (CLL).

Clinical Pearls

Adrian Wiestner, MD, PhD, senior investigator, National Institutes of Health, discusses curing or managing patients with chronic lymphocytic leukemia (CLL).

  • The question remains as to whether CLL can be cured or if it should be managed over the long term.
  • This answer depends on the age and comorbidities of the patient.
  • The safety of CLL drugs over the course of many years in unknown.

<<<

Go back to the ASH conference page